Skip to main navigation

Skip to content

Skip to content

About PDL
- Leadership
Equity Investments
Alternative Financings
Investor Relations
News
Contact

About PDL
- Management
Equity Investments
Alternative Financings
Investor Relations
News
Contact

Tax Information

PDL > Investor Relations > Tax Information

Tax Information

Section 1.1273-2(f) Disclosure Statement 70.3 KB

Form 8937 1.2 MB

Investor Relations

Evofem Distribution and Tax Information
Press Releases
Events & Presentations
Corporate Governance
Financials & Filings
Convertible Note Tax Information
- Section 1.1273-2(f) Disclosure Statement
- Form 8937
SEC Filings
Stock Information
Contact Us

Current Alternative Investments

Shareholder Tools

Printed Materials
Email Alerts
RSS
Print
Share
Search

Facebook
Google
LinkedIn
Twitter
RSS

Terms of Use
Sitemap

© Copyright 2019 PDL BioPHARMA. All Rights Reserved.